Quoted from //www.medpagetoday.com/MeetingCoverage/ELCC/32298
RT May Have Role in Mesothelioma
Patients with advanced, poor-risk mesothelioma lived for as long as 7 years after treatment with high-dose, hemithoracic radiation therapy, data from a small patient series showed.
The 45 patients had a median overall survival of 12.4 months from treatment and an estimated 1-year survival of 50%. No patient had in field-only recurrent disease following treatment with conformal or intensity-modulated radiation therapy (IMRT).
The findings dispute the notion that mesothelioma is radiation insensitive, Malcolm Feigen, MD, said here at the European Lung Cancer Conference (ELCC).
“I stood before [the ELCC] 2 years ago to present the first 14 patients we had analyzed and asked whether there was a role for high-dose hemithoracic radiotherapy in unpneumonectomized mesothelioma patients,” said Feigen, of the Austin Health Radiation Oncology Center in Melbourne, Australia. “I think now that the answer to that question is ‘absolutely.'”